Copyright © 1993 by the European Society of Cardiology.
© 1993 The European Society of Cardiology
Deleterious effect of exogenous angiotensin-I on the extent of regional ischaemia and its inhibition by captopril
Institut für Pharmakologie Universität Köln Germany
Received 27 August 1991; revised 8 June 1992; .
Correspondence: A. F E Rump, Institui für Pharmakologie, Universität zu Köln. Gleuclersiraße 24, D-5000 Köln 41, Germany
Abstract
The endogenous activity of the local renin-angiotensin system (RAS) and the anti-ischaemic properties of captopril were investigated in electrically driven rabbit Langendorff hearts (constant pressure: 70 cmH2O, Tyrode solution, Ca2+ 1.8 mmol.l1). Cumulative concentration-response curves showed no significant difference (P>0.05) between the reduction of the global coronary flow (CF) by exogenous angiotensin-I or angiotensin-II (EC50 = 1010 mol.l1). It is concluded that the local RAS in isolated rabbit hearts is highly sensitive, whereas its endogenous activity is very low due to very low endogenous angiotensin-I content. Myocardial ischaemia (MI) was induced by the occlusion of a left coronary artery branch and MI was quantified from NADH surface fluorescence photography. MI was significantly enlarged (+35%) (P <0.05) by exogenous angiotensin-I (6x109 mol.l1). The reduction in CF and the increment in MI by angiotensin-I could be completely prevented by adding captopril at a low concentration (106 mol.l1) to the perfusion buffer. In the absence of exogenous angiotensin-I, captopril alone (106 mol.l1) neither significantly enhanced CF (P >0.05), nor diminished MI (P >0.05), supporting the finding of very low endogenous activity of tile local RAS in this model. We, moreover, conclude that at a low concentration (106 mol.l1) captopril does not possess direct cardioprotective properties independent of its ACE inhibiting action.
Key Words: NADH fluorescence angiotensin angiotensin-converting enzyme myocardial ischaemia ACE inhibitors captopril cardioprotection